Skip to main content
Novartis
language-selector-globe United States | en
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe us
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 
      • Novartis in the US 
        • Diversity equity & inclusion  
        • Pay transparency-EPIC 
        • Our code of ethics 
      • Diversity, equity & inclusion  
        • Novartis US EEO / D&I report 2021 
        • Supplier diversity 
      • People and culture 
      • Products 
      • US Country Coordinating Committee 
      • External funding 
      • Contact us 
      Team meeting About
    • Patients and caregivers 
      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 
        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
      • Participating in clinical trials 
      • Patient perspectives 
      • Adverse event reporting 
      • The STEP program 
        • Sickle cell disease (SCD) 
        • Program overview 
        • Multiple sclerosis (MS) 
        • Cancer 
        • Application for funding to help address health disparities 
        • Health disparities 
      • Patient resources 
      Patient smiling at doctor image Patients and caregivers
    • Healthcare professionals 
      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray Healthcare professionals
    • ESG 
      • Ethical behavior 
        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 
        • Population health 
        • Novartis in society US reports 
        • Novartis US Foundation 
        • Environmental sustainability 
        • People and communities 
      • Beacon of hope 
        • Beacon of hope: Measurable solutions for health equity 
        • Paving the way for a brighter, more equitable future 
      Novartis East Hanover Campus Landscaping ESG
    • News 
      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting News
    • Careers 
      • Career search 
      • Meet the teams 
      • Early career 
      • Personal growth 
      • How we work 
      • Employee benefits 
      • Diversity, equity & inclusion 
      • Awards & recognition 
      Meeting in Atrium Careers
    Grandmother, mother and daughter smiling and laughing on a beach Home
  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Cardiologist Physician Scientist (Associate Director/Director) Cambridge (USA) USA Biomedical Research Pharma Research Research & Development Aug 05, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
Product Specialist Guangzhou (Guangdong Province) China International Innovative Medicines Sales Aug 05, 2024
MR Fuyang (Anhui Province) China International Innovative Medicines Sales Aug 05, 2024
(高级)医药代表 /(资深)产品专员 Qinnan (Guizhou Province) China International Innovative Medicines Sales Aug 04, 2024
Elektroniker (m/w/d) der Fachrichtung Betriebstechnik im Bereich Facility Management Wehr (Novartis Pharma Produktions GmbH) Germany Operations Innovative Medicines Technical Operations Aug 02, 2024
Mechaniker (m/w/d) im Bereich Facility Management Wehr (Novartis Pharma Produktions GmbH) Germany Operations Innovative Medicines Technical Operations Aug 02, 2024
Engineer (Multidiscipline) (m/w/d) im Bereich Facility Management Wehr (Novartis Pharma Produktions GmbH) Germany Operations Innovative Medicines Technical Operations Aug 02, 2024
Facility Expert (m/w/d) im Bereich Facility Management (80%) Wehr (Novartis Pharma Produktions GmbH) Germany Operations Innovative Medicines Technical Operations Aug 02, 2024
Sr. Automation Engineer Carlsbad USA Operations CTS Research & Development Aug 02, 2024
Senior Global Program Clinical Head, Oncology East Hanover USA Development Innovative Medicines Research & Development Aug 02, 2024
Sales Value Associate CDMX - Privado INSURGENTES Mexico International Innovative Medicines Sales Aug 01, 2024
Head Engineering (m/f/d) Puurs Belgium Operations Innovative Medicines Technical Operations Aug 01, 2024
Technical System Lead (Qualification) Sasayama Japan Operations Innovative Medicines Technical Operations Jul 31, 2024
Pricing Manager New South Wales (NSW) Australia International Innovative Medicines Market Access Jul 31, 2024
MS&T Expansion Lead RLT Sasayama Sasayama Japan Operations Innovative Medicines Technical Operations Jul 31, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Third Party Risk Management Specialist Prague Czech Republic Operations CTS Procurement Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Senior MR Guangzhou (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
County Executive Maoming (Guangdong Province) China International Innovative Medicines Sales Jul 30, 2024
Product Specialist Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 30, 2024
Global Procurement Category Manager, Chemicals Prague Czech Republic Operations CTS Procurement Jul 29, 2024
Clinical Development Medical Manager Shanghai (Shanghai) China Development Innovative Medicines Research & Development Jul 29, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
MR Wuhan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024
R2R Specialist - Inventory Selangor Malaysia Finance CTS Audit & Finance Jul 28, 2024
County Executive Xiaogan (Hubei Province) China International Innovative Medicines Sales Jul 28, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • …
  • 42
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information
  • Global site
Footer Bottom
© 2024 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only